Results 181 to 190 of about 207,426 (323)
Seasonal variation in the incidence of central serous chorioretinopathy: A systematic review and meta‐analysis
Acta Ophthalmologica, EarlyView.Abstract
Central serous chorioretinopathy (CSC) is a chorioretinal disease characterised by serous subretinal fluid (SRF) in the macula, resulting in sudden central vision loss. It predominantly affects working‐age adults, particularly men aged 30 to 60 years.I. Made Ferdiko Hutamadella, Emil Ørnberg, Mark P. Breazzano, Lasse Jørgensen Cehofski, Chui Ming Gemmy Cheung, Kristina Pfau, M. Cem Sabaner, Lorenzo Ferro Desideri, Camiel J. F. Boon, Yousif Subhi, Elon H. C. van Dijk +10 morewiley +1 more sourceA randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.
A M A Archives of Ophthalmology, 2001 A. Kassoff, J. Kassoff, J. Buehler, M. Eglow, F. Kaufman, M. Mehu, S. Kieval, M. Mairs, B. Graig, A. Quattrocchi, David R. Jones, J. Locatelli, A. Ruby, A. Capon, B. Garretson, T. Hassan, M. Trese, George A. Williams, V. Regan, P. Manatrey, P. Streasick, L. Szydlowski, F. McIver, C. Bridges, C. Stanley, K. Cumming, B. Lewis, M. Zajechowski, R. Margherio, M. Cox, J. Werner, R. Falk, P. Siedlak, C. Neubert, M. Klein, J. T. Stout, A. O'Malley, A. Lauer, J. Robertson, David J. Wilson, C. Beardsley, H. Anderson, P. Wallace, G. Smith, S. Howard, R. Dreyer, C. Ma, R. G. Chenoweth, J. Zilis, M. Johnson, P. Rice, H. Daniel, H. Crider, S. Parker, K. Sherman, Daniel F. Martin, T. Aaberg, P. Sternberg, L. T. Curtis, B. Ju, J. Gilman, B. Myles, S. Strittman, C. Gentry, H. Yi, A. Capone, M. Lambert, T. Meredith, T. Aaberg, D. Saperstein, Jennifer I. Lim, B. Stribling, D. Armiger, R. Swords, D. Orth, T. Flood, J. Civantos, S. deBustros, K. Packo, P. Merrill, J. Cohen, C. Figliulo, C. Morrison, D. Bryant, D. Doherty, M. McVicker, T. Drefcinski, J. Seddon, M. Pinnolis, N. Davis, I. Burton, T. Taitsel, D. Walsh, J. Dubois-Moran, C. Callahan, C. Evans, K. K. Snow, D. A. Jones-Devonish, V. Crouse +98 moresemanticscholar +1 more sourceAge-Related Macular Degeneration, Cardiovascular Disease and Stroke [PDF]
, 2021 Gerardo Ledesma‐Gil, Oscar Otero-Marquez, Sharmina Alauddin, Yuehong Tong, Wei Wei, Katy Tai, Harriet O. Lloyd, Micaela Koci, Catherine Ye, Cinthi Pillai, Maria Scolaro, Arun Govindaiah, Alauddin Bhuiyan, Avnish Deobhakta, Richard B. Rosen, Lawrence A. Yannuzzi, K. Bailey Freund, R. Theodore Smith +17 moreopenalex +1 more sourceThe physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system
Brain Pathology, EarlyView.Sphingolipids are vital components of cell membranes. Metabolic disruptions of sphingolipids, including ceramide and sphingosine‐1‐phosphate, are linked to neurological disorders. This article summarizes the classification, structure, and metabolic processes of sphingolipids, and the physiological and pathological effects of sphingolipid metabolism and Tian Li, Haoying He, Ejuan Zhang, Fengjiao Hu, Zhuo Wang, Jian Xu, Mengliu Zeng, Biwen Peng +7 morewiley +1 more sourceOutcomes After Switching to Faricimab in Neovascular Age‐Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background
We aimed to describe 1‐year outcomes of eyes switched to faricimab from first‐generation vascular endothelial growth factor (VEGF) inhibitors for neovascular age‐related macular degeneration (nAMD) in routine care. Methods
Multicentre, observational study of 383 eyes tracked in the Fight Retinal Blindness!Adrian Hunt, Yohei Hashimoto, Stephanie Young, Jennifer Arnold, Justin Game, Claire Hooper, Andrew Field, Richard Barry, Daniel Barthelmes, Mark Gillies +9 morewiley +1 more sourceDeep Learning‐Based Detection of Reticular Pseudodrusen in Age‐Related Macular Degeneration
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background
Reticular pseudodrusen (RPD) signify a critical phenotype driving vision loss in age‐related macular degeneration (AMD). This study sought to develop and externally test a deep learning (DL) model to detect RPD on optical coherence tomography (OCT) scans with expert‐level performance.Himeesh Kumar, Yelena Bagdasarova, Scott Song, Doron G. Hickey, Amy C. Cohn, Mali Okada, Robert P. Finger, Jan H. Terheyden, Ruth E. Hogg, Pierre‐Henry Gabrielle, Louis Arnould, Maxime Jannaud, Xavier Hadoux, Peter van Wijngaarden, Carla J. Abbott, Lauren A. B. Hodgson, Roy Schwartz, Adnan Tufail, Emily Y. Chew, Cecilia S. Lee, Erica L. Fletcher, Melanie Bahlo, Brendan R. E. Ansell, Alice Pébay, Robyn H. Guymer, Aaron Y. Lee, Zhichao Wu +26 morewiley +1 more sourceTen‐Year Incidence, Risk Factors and Progression Rate of Macular Atrophy in Neovascular Age‐Related Macular Degeneration
Clinical &Experimental Ophthalmology, EarlyView.ABSTRACT Background
To evaluate the 10‐year cumulative incidence, progression rates, and risk factors for macular atrophy (MA) in neovascular age‐related macular degeneration (nAMD) patients receiving long‐term anti‐vascular endothelial growth factor (VEGF) therapy.Francesco Romano, Marco Casaluci, Antonio Valastro, Matteo Airaldi, Paolo Milella, Francesco Pozzo Giuffrida, Elisa Cozzi, Andrea Aretti, Kelvin YC Teo, Chui Ming Gemmy Cheung, Marco Nassisi, Francesco Viola, Giovanni Staurenghi, Alessandro Invernizzi +13 morewiley +1 more source
